SEC Tracker
Get the app

Jaguar Health JAGX

Jaguar Health approved six proposals at special meeting.

Item 5.07 Shareholder vote results, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Notable
  1. 6 proposals approved by stockholders.
  2. 3,383,169 shares of common stock voted.
  3. Series Q Preferred Stock votes totaled 58.97 shares.
  4. Reverse stock split proposal approved under Votes Cast Standard.

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Jaguar Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  2. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  3. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  4. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  5. Healthy Extracts HYEX public float $4M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.